May 23, 2022
What actions medical device manufacturers could take to strengthen the implementation strategy for EU MDR and IVDR? [Recording: 15 video sessions].
March 30, 2022
What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? [Recording: 12 video sessions].
December 2, 2021
Review comprehensive drug impurity profiling strategies in line with regulatory guidelines on new nitrosamine regulations. [Recording: 14 video sessions].
September 29, 2021
Explore how pioneering pharma companies are approaching innovative HPAPI development and processing challenges. [Recording: 12 video sessions].
May 19, 2021
Analytical methods for E&L, regulatory updates & compliance, risk based E&L programs, toxicological risk assessment. [Recording: 13 video sessions].
April 28, 2021
How to benchmark R&D activities and restructure R&D teams to protect against disruption and find new ways of innovation? [Recording: 15 video sessions].
September 28, 2026
June 3, 2027
May 28, 2026